Zhao Dong

Title: Innovations of Inventor Zhao Dong

Introduction

Zhao Dong is a prominent inventor based in Shanghai, China. He has made significant contributions to the field of biopharmaceuticals, particularly in the development of proteins that regulate blood glucose and lipid metabolism. With a total of three patents to his name, Zhao Dong is recognized for his innovative approaches to addressing metabolic disorders.

Latest Patents

Zhao Dong's latest patents include a dual-function protein for lipid and blood glucose regulation. This protein comprises a human GLP-1 analog and human FGF21, which work synergistically to regulate blood glucose and lipid levels in vivo. The invention also outlines a method for preparing this dual-function protein, which can be used in treating type 2 diabetes, obesity, dyslipidemia, fatty liver disease, and metabolic syndrome. Another notable patent is a linker peptide for constructing fusion proteins. This linker peptide consists of flexible and rigid components that enhance the stability and bioavailability of the fused protein, thereby improving its therapeutic potential.

Career Highlights

Zhao Dong is currently employed at Ampsource Biopharma Shanghai Inc., where he continues to innovate in the biopharmaceutical sector. His work focuses on developing advanced therapeutic proteins that can significantly improve patient outcomes in metabolic health.

Collaborations

Zhao Dong collaborates with esteemed colleagues, including Qiang Li and Yuanli Li, who contribute to his research and development efforts. Their combined expertise enhances the innovative capacity of their projects.

Conclusion

Zhao Dong's contributions to the field of biopharmaceuticals exemplify the impact of innovative thinking in addressing critical health issues. His patents reflect a commitment to improving treatments for metabolic disorders, showcasing the importance of research and collaboration in advancing medical science.